Compliance Should Accelerate Innovation

What if the biggest bottleneck in MedTech innovation isn't science—but compliance?

In this episode of Med Tech Gurus, we sit down with Zahra Timsah, Founder and CEO of i-GENTIC AI, to explore how artificial intelligence is transforming FDA readiness, regulatory operations, and healthcare compliance.

With experience spanning oncology research, drug discovery, engineering, and international regulatory systems, Zahra brings a rare perspective to one of healthcare's least glamorous—but most consequential—challenges: getting innovation through the regulatory bottleneck and into patients' hands faster.

What makes her story especially compelling is that this mission is personal. After witnessing a life-saving diagnostic delayed by regulatory friction, Zahra began pursuing a different vision: using AI not to replace expertise, but to augment it.

We dive into her concept of "governance by design," where compliance becomes proactive instead of reactive, embedded into every stage of development rather than treated as a last-minute hurdle. Zahra also explains how contextual AI agents can act like a "digital FDA reviewer," helping companies identify inconsistencies, reduce documentation friction, and prepare stronger submissions before they ever reach regulators.

The conversation also explores why most operational bottlenecks are documentation-driven rather than scientific, why specialized AI matters more than general-purpose tools, and how AI-assisted services may become the next major evolution in healthcare compliance.

If you're interested in AI in healthcare, FDA strategy, MedTech compliance, regulatory affairs, healthcare AI, or digital quality systems, this episode delivers a compelling look at how intelligent compliance may become a competitive advantage for the next generation of MedTech innovators.